These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8750261)

  • 1. Standards for specialist units undertaking blood and marrow stem cell transplants--recommendations from the EBMT. Accreditation Sub-Committee of the European Group for Blood and Marrow Transplantation (EBMT).
    Link H; Schmitz N; Gratwohl A; Goldman J
    Bone Marrow Transplant; 1995 Dec; 16(6):733-6. PubMed ID: 8750261
    [No Abstract]   [Full Text] [Related]  

  • 2. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, Center for International Blood and Marrow Transplant Research, and the American Society for Blood and Marrow Transplantation (EBMT/CIBMTR/ASBMT).
    Rizzo JD; Wingard JR; Tichelli A; Lee SJ; Van Lint MT; Burns LJ; Davies SM; Ferrara JL; Socié G
    Bone Marrow Transplant; 2006 Feb; 37(3):249-61. PubMed ID: 16435004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood and marrow transplantation activity in Europe 1997. European Group for Blood and Marrow Transplantation (EBMT).
    Gratwohl A; Passweg J; Baldomero H; Hermans J
    Bone Marrow Transplant; 1999 Aug; 24(3):231-45. PubMed ID: 10456992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood and marrow transplantation activity in Europe 1996. European Group for Blood and Marrow Transplantation (EBMT).
    Gratwohl A; Passweg J; Baldomero H; Hermans J
    Bone Marrow Transplant; 1998 Aug; 22(3):227-40. PubMed ID: 9720735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A European reference protocol for quality assessment and clinical validation of autologous haematopoietic blood progenitor and stem cell grafts.
    Serke S; Johnsen HE
    Bone Marrow Transplant; 2001 Mar; 27(5):463-70. PubMed ID: 11313679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standards of stem cell transplantation: Part I: the accreditation of paediatric stem cell transplantation centres within the EBMT; Part II: intensive care units in paediatric stem cell transplantation; Part III: informed consent and sibling donor issues.
    Cornish J; Peters C
    Bone Marrow Transplant; 2001 Aug; 28 Suppl 1():S4-5. PubMed ID: 11571522
    [No Abstract]   [Full Text] [Related]  

  • 7. Hematopoietic stem cell transplants after reduced intensity conditioning regimen (RI-HSCT): report of a workshop of the European group for Blood and Marrow Transplantation (EBMT).
    Bacigalupo A
    Bone Marrow Transplant; 2000 Apr; 25(8):803-5. PubMed ID: 10808199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood and marrow transplantation activity in Europe 1995. European Group for Blood and Marrow Transplantation (EBMT).
    Gratwohl A; Hermans J; Baldomero H
    Bone Marrow Transplant; 1997 Mar; 19(5):407-19. PubMed ID: 9052905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Happy birthday to Joint Accreditation Committee for ISCT Europe and EBMT].
    Caunday O; Faucher C; Milpied N; Chabannon C
    Med Sci (Paris); 2010; 26(6-7):652-4. PubMed ID: 20619170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood and marrow stem cell transplants in auto-immune disease: a consensus report written on behalf of the European League against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT).
    Tyndall A; Gratwohl A
    Bone Marrow Transplant; 1997 Apr; 19(7):643-5. PubMed ID: 9156239
    [No Abstract]   [Full Text] [Related]  

  • 11. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation.
    Rizzo JD; Wingard JR; Tichelli A; Lee SJ; Van Lint MT; Burns LJ; Davies SM; Ferrara JL; Socié G
    Biol Blood Marrow Transplant; 2006 Feb; 12(2):138-51. PubMed ID: 16443512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. JACIE accreditation in paediatric haemopoietic SCT.
    Cornish JM
    Bone Marrow Transplant; 2008 Oct; 42 Suppl 2():S82-6. PubMed ID: 18978752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transplantation activities and treatment strategies in paediatric stem cell transplantation centres: a report from the EBMT Working Party on Paediatric Diseases. European Group for Blood and Marrow Transplantation.
    Peters C; Ladenstein R; Minkov M; Pötschger U; Gadner H; Cornish J; Dini G; Klingebiel T; Locatelli F; Vossen J; Niethammer D
    Bone Marrow Transplant; 1998 Sep; 22(5):431-7. PubMed ID: 9733265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proposal for standard recommendations for prophylaxis of graft-versus-host disease in children. European Group for Blood and Marrow Transplantation (EBMT) Working Party Paediatric Diseases and the International Study Committee of the BFM family-subcommittee Bone Marrow Transplantation (IBFM-STG).
    Peters C; Minkov M; Gadner H; Klingebiel T; Niethammer D
    Bone Marrow Transplant; 1998 Apr; 21 Suppl 2():S57-60. PubMed ID: 9630328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Change in stem cell source for hematopoietic stem cell transplantation (HSCT) in Europe: a report of the EBMT activity survey 2003.
    Gratwohl A; Baldomero H; Schmid O; Horisberger B; Bargetzi M; Urbano-Ispizua A
    Bone Marrow Transplant; 2005 Oct; 36(7):575-90. PubMed ID: 16086045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Turkish Transplant Registry: a comparative analysis of national activity with the EBMT European Activity Survey.
    Arat M; Arpaci F; Ertem M; Gürman G;
    Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S142-S145. PubMed ID: 18724290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe in 1998. Accreditation Sub-Committee of the European Group for Blood and Marrow Transplantation.
    Goldman JM; Schmitz N; Niethammer D; Gratwohl A
    Bone Marrow Transplant; 1998 Jan; 21(1):1-7. PubMed ID: 9486487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation and extension of the EBMT Risk Score for patients with chronic myeloid leukaemia (CML) receiving allogeneic haematopoietic stem cell transplants.
    Passweg JR; Walker I; Sobocinski KA; Klein JP; Horowitz MM; Giralt SA;
    Br J Haematol; 2004 Jun; 125(5):613-20. PubMed ID: 15147377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation.
    Tichelli A; Passweg J; Wójcik D; Rovó A; Harousseau JL; Masszi T; Zander A; Békássy A; Crawley C; Arat M; Sica S; Lutz P; Socié G;
    Haematologica; 2008 Aug; 93(8):1203-10. PubMed ID: 18556401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Voluntary accreditation of cellular therapies: Foundation for the Accreditation of Cellular Therapy (FACT).
    Warkentin PI;
    Cytotherapy; 2003; 5(4):299-305. PubMed ID: 12944235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.